| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $89.44M | -5,000 | |
| CEO | 383.9K | $26.58M | - | |
| VP | 105.3K | $7.29M | -627 | |
| CFO | 84.0K | $5.82M | - | |
| VP | 79.1K | $5.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Lee Scott Golden | EVP & Chief Medical Officer | Sell10b5-1 | 2,008 | $44.84 | $90,036.40 | -2.5% | -11.7% | +70.6% | |
| Jan 8, 2025 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 4,544 | $44.90 | $204,007.28 | -1.6% | -11.7% | +70.6% | |
| Jan 8, 2025 | Eric Pauwels61 | Chief Executive Officer | Sell10b5-1 | 3,735 | $44.86 | $167,550.66 | -4.1% | -11.7% | +70.6% | |
| Jan 8, 2025 | Christine Marie Utter58 | SVP, Chief Accounting Officer | Sell10b5-1 | 2,953 | $44.87 | $132,492.94 | -4.4% | -11.7% | +70.6% | |
| Dec 31, 2024 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 8,279 | $45.16 | $373,879.64 | -3.7% | +12.9% | +68.3% | |
| Dec 3, 2024 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE10b5-1 | 95,908 | $52.37 | $5,022,334.27 | -50.9% | +5.1% | +50.6% | |
| Dec 2, 2024 | Christine Marie Utter58 | SVP, Chief Accounting Officer | Sale+OE10b5-1 | 17,800 | $51.77 | $921,585.17 | -25.3% | +1.5% | +50.7% | |
| Dec 2, 2024 | Jerome B Zeldis45 | Director | Sale+OE10b5-1 | 24,000 | $51.50 | $1,235,897.49 | -62.3% | +1.5% | +50.7% | |
| Dec 2, 2024 | Neil Gregory Almstead55 | Chief Technical Ops Officer | Sale+OE10b5-1 | 71,610 | $52.06 | $3,727,957.62 | -94.0% | +1.5% | +50.7% | |
| Jul 16, 2024 | Pierre Gravier55 | Chief Financial Officer | Sell10b5-1 | 2,269 | $34.02 | $77,200.46 | -4.1% | +14.5% | +40.9% |